A global AI in pharma and biotech industry valuation of US$ 1.8 billion was estimated for 2023. The market will reach US$ 13.1 billion by 2034, with a CAGR of 18.8% between 2024 and 2034. Healthcare ...

13, 2024 (GLOBE NEWSWIRE) -- The "Laboratory Equipment Services ... the surge in R&D investments in biotechnology and pharmaceutical sectors demands enhanced equipment uptime and performance, further ...

LON­DON — Demis Has­s­abis has no in­ter­est in a lab­o­ra­to­ry. The No­bel Prize-win­ning ar­ti­fi­cial in­tel­li­gence pi­o­neer is bet­ting big on AI’s fu­ture in drug ...

AI-Immunology is crucial in allowing the identification of therapeutically relevant ERV tumor antigens from genomic patient tumor data. Contact information Evaxion Biotech A/S Mads Kronborg Vice ...

Evaxion Biotech (EVAX) obtains preclinical Proof-of ... Switzerland. Evaxion’s AI-Immunologyplatform can identify and select vaccine targets from ERVs expressed in the cancer cells, enabling ...

Earlier this week, life sciences venture firm Dimension Capital announced it had raised a new $500 million second fund — just two years after its first — to hunt for startups that are using artificial ...

q2-amrfinderplus: QIIME 2 plugin to find acquired antimicrobial resistance genes and point mutations in protein and/or assembled nucleotide sequences with AMRFinderPlus.

AI-driven biotech BenevolentAI (Euronext: BAI) has announced sweeping changes aimed at refocusing its operations and extending its financial runway into 2027. The changes include a potential delisting ...

The home page of the Laboratory for Generative AI Solutions for Information Retrieval Applications (GAIR 🍀) at the School of Computing Science, University of Glasgow. GAIR-Lab is led by Prof. Joemon ...